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Commonly found at the outermost ends of complex carbohydrates in extracellular medium
or on outer cell membranes, sialic acids play important roles in a myriad of biological pro-
cesses. Mammals synthesize sialic acid through a complex pathway, but Trypanosoma
cruzi, the agent of Chagas’ disease, evolved to obtain sialic acid from its host through a
trans-sialidase (TcTS) reaction. Studies of the parasite cell surface architecture and bio-
chemistry indicate that a unique system comprising sialoglycoproteins and sialyl-binding
proteins assists the parasite in several functions including parasite survival, infectivity, and
host–cell recognition. Additionally, TcTS activity is capable of extensively remodeling host
cell glycomolecules, playing a role as virulence factor. This review presents the state of
the art of parasite sialobiology, highlighting how the interplay between host and parasite
sialic acid helps the pathogen to evade host defense mechanisms and ensure lifetime host
parasitism.
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THE SIALIC ACIDS
Sialic acids (Sia) are 9-carbon backbone acidic monosaccharides
found at prominent positions of the sugar chains of glycoconju-
gates present on cell membranes or secreted into the extracellular
medium. The most common members of this family are the
N-acetylneuraminic acid [Neu5Ac] and its derivative the N-
glycolylneuraminic acid [Neu5Gc] that differ from each other at
position 5 (C-5), which is substituted with an acetamido or a
hydroxyacetamido moiety respectively (Figure 1).
The metabolism of Sia in mammals involves 32 genes that
encode enzymes and transporters, distributed among the differ-
ent compartments of the cell (Wickramasinghe and Medrano,
2011). The ﬁnal product of this complex biosynthetic pathway,
the activated form of Sia (CMP-Sia), is transferred to the non-
reducing end of newly synthesized glycan chains by a family of
sialyltransferases present in theGolgi lumen. In vertebrates, Sia are
commonly linked via an α2–3 linkage to galactopyranose (Galp),
via an α2–6 linkage to Galp and N-acetylgalactosamine (GalNAc),
or via an α2–8 linkage to another Sia (Varki et al., 2009).
Sia-containing glycoconjugates are involved in a myriad of cell
functions. Because of the negative charge, these molecules affect
the recognition and anti-recognition phenomena. They are targets
of Sia-binding lectins and can mask underlying structures, for
example impeding the binding of Gal-speciﬁc receptors (Sørensen
et al., 2009; Rabinovich et al., 2012).
Sia are also important as recognition sites in host–pathogen
interactions acting as ligands for parasite adherence, possibly driv-
ing natural selection (Varki, 2006). Further, Sia play a major role
protecting the infective agent from the host’s immune response
through molecular mimicry while unsialylated strains are rapidly
cleared. The evolutionary advantage of this molecular mimicry is
so evident that several parasites exploit cell-surface sialylation to
survive within the host environment and establish the infection
(Vimr and Lichtensteiger, 2002).
One of the most elegant mechanisms of cell-surface sialylation
is exploited by the protozoal parasite Trypanosoma cruzi, the etio-
logical agent of Chagas’ disease (Coura and Viñas, 2010). T. cruzi
is not able to synthesize Sia. Instead the parasite scavenges it from
host’s sialyl glycoconjugates using its trans-sialidase activity (TcTS;
Previato et al., 1985). TcTS is a modiﬁed sialidase, which preferen-
tially transfers α2-3-linked Sia from sialyl β-Galp donor complexes
of exogenous origin to acceptor surface mucin-like glycoproteins
containing terminal β-galactopyranose residues (Figure 2). In the
absence of suitable acceptors TcTS transfers Sia to water, then
acting as a sialidase (Vandekerckhove et al., 1992).
Once restricted to Latin America, where it affects ∼10 million
people, Chaga’s disease become a new worldwide challenge. It has
now spread to North America, Europe, and the western Paciﬁc
region (Chappuis et al., 2010; Clayton, 2010). Molecules of the
TcTS family (Freitas et al., 2011) and Sia acceptor glycoproteins
(De Pablos and Osuna, 2012) are encoded by hundreds of genes.
Combined, the TcTS and the mucin-like glycoproteins are likely to
cover most of the parasite surface (Figure 3B) creating a parasite–
host interface (Figure 3A)
In this review we discuss the importance of this unique biolog-
ical system, comprised by both TcTS and mucin-like Sia acceptor
glycoproteins, highlighting how the parasite explores host cell
sialylation to establish infection for the lifetime of its host.
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FIGURE 1 |The two major sialic acid found in mammals. (A) N -acetylneuraminic acid [Neu5Ac] and, (B) N -glycolylneuraminic acid [Neu5Gc].
FIGURE 2 | Representation of transfer and hydrolysis activities ofTcTS.
TcTS preferentially catalyzes the transfer of sialic acid residues from
Siaα2–3Galβ1-R containing donors and attaches them in α2–3 linkage to
terminal β-Galp containing acceptors (transfer reaction). In the absence of a
carbohydrate acceptor, TcTS irreversibly transfers sialic acid to a water
molecule, thus functioning as a sialidase (hydrolysis reaction).
THE SIALIC ACID ACCEPTORS ON THE SURFACE OF THE
PARASITE AND ITS ROLE IN HOST PARASITE INTERACTION
The Sia acceptors on the surface of T. cruzi are mainly a family
of highly O-glycosylated, threonine-rich mucin like glycoproteins
(Figure 3D; Buscaglia et al., 2006; Mendonça-Previato et al., 2008)
which are glycosylphosphatidylinositol (GPI)-anchored to thepar-
asite membrane (Previato et al., 1995). The Tc-mucins are the
major expressed component on the of T. cruzi (2 × 106 copies
per parasite) and are the third most widely expanded gene family
in the genome, comprising more than 1000 genes (Acosta-Serrano
et al., 2001; Campo et al., 2004; El-Sayed et al., 2005; De Pablos and
Osuna, 2012). Carrying up to 60% of its total mass in carbohy-
drates, mucins form an elaborate and highly decorated glycocalyx
that allows the parasite to interact with and respond to its exter-
nal environment. Furthermore, glycoproteins expressed on the
parasite surface are known to be the major targets of protective
immune responses, and this selective pressure presumably drives
their expansion and variation among different strains (Minning
et al., 2011).
The glycan structure of mucin is complex and heterogeneous
among different T. cruzi strains. The structure of the oligosaccha-
rides O-linked to the mucins of the non-infective epimastigote
forms have been described (Previato et al., 1994, 1995; Todes-
chini et al., 2001, 2009; Agrellos et al., 2003; Jones et al., 2004).
These O-glycans differ from those found in mammalian systems
in three main aspects: (i) they are linked to the peptide backbone
through an α-N-acetylglucosamine (α-GlcNAc) residue (Previato
et al., 1998), rather than an α-N-acetylgalactosamine (α-GalNAc;
Gill et al., 2011); (ii) they are further substituted by (Gal) on O-4
and O-6 rather than O-3 and O-6 as found in mammalian mucins
(Varki et al., 2009); (iii) several strains carry a β-galactofuranose
(β-Galf) attached to theGlcNAcO-4 (Previato et al., 1994; Agrellos
et al., 2003; Jones et al., 2004). Two core families were characterized
with substitution of the α-GlcNAc O-4 by either β-Galp or β-Galf.
The Galfβ1-4GlcNAc core can be further elaborated by the action
of galactopyranosyl or galactofuranosyl transferases. Additionally,
substitution at the GlcNAc-ol O-6 can occur. Addition of β-Galf
to mucins must be veriﬁed given that T. cruzi presents dozens β-
galactofuranosyl transferase genes (El-Sayed et al., 2005; De Pablos
and Osuna, 2012) while mammalian hosts glycoconjugates do not
present this modiﬁcation. β-Galf residues might account for host
parasite selection since the presence of β-Galf-containing mucins
are expressed mainly by strains involved in the sylvatic cycle of
T. cruzi (Jones et al., 2004).
The major sialylated oligosaccharides (Figure 3C) so far char-
acterized comprise a Neu5Acα2-3Galpβ1-4GlcNAc (Jones et al.,
2004), a Galfβ1-4(Neu5Acα2-3Galpβ16)GlcNAc (Agrellos et al.,
2003), a Galpβ1-4(Neu5Acα2-3Galpβ1-6)GlcNAc, and a Galpβ1-
6(Neu5Acα2-3Galpβ(1-4)GlcNAc (Todeschini et al., 2001). Char-
acterization of the related monosialylated glycans conﬁrms a
previous report showing that incorporation of one Sia residue
onto an acceptor hinders entry of a second residue (Previato
et al., 1995). Thus, it is possible that concomitant presence of
both α2-3-linked Sia and terminal β-Galp residues have biological
implications in the T. cruzi/host cell interaction.
In addition to the O-glycosylation observed in the mucins
of epimastigote forms, mucin glycans of infective trypomastig-
otes derived from infected mammalian cells also contain terminal
α-galactosyl residues. α-Gal containing saccharides are epitopes
recognized by lytic antibodies found in chronic Chagasic patients
(Almeida et al., 1994). Sialylation of parasite glycoconjugates con-
fers signiﬁcant resistance to killing by the lytic antibodies, which
is in agreement with the hypothesis that sialylation must favor
parasite survival (Pereira-Chioccola et al., 2000). Further evidence
corroborating this hypothesis is that the presence of Sias on the
parasite mucins may compromise the activation of the comple-
ment pathway (Tomlinson et al., 1994). After sialidase treatment,
parasites become more sensitive to complement-induced lysis.
Also, parasite uptake by macrophages is increased (Tomlinson
et al., 1994).
The importance of Sia on the parasite surface during host cell
infection is still controversial. While some studies have shown
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FIGURE 3 | Representation of theTcTS/sialoglycoproteins system
onT. cruzi trypomastigotes surface. (A) A scanning electron micrograph
of a bloodstream formT. cruzi trypomastigote (www.ﬁocruz.br/
chagas_eng/cgi/cgilua.exe/sys/start.htm?sid=13) is shown. (B)The cartoon
represents the GPI-anchoredTcTS, TcTSY342H/sialoglycoproteins covering
the trypomastigote surface. Sia present onT. cruzi sialoglycoproteins (C) is
transfered from host sialoglycoconjugates to β-Galp containing glycoproteins
expressed on parasite surface (D) byTcTS activity.
that the presence of Sias in parasite epitopes increases T. cruzi
infection (Piras et al., 1987; Schenkman et al., 1991), other groups
suggest that the presence of Sias is not a requirement and/or may
compromise the invasion of host cells (Araújo-Jorge andDe Souza,
1988; Yoshida et al., 1997).
Finally, there are increasing evidences to support the Sia-
binding Ig-like lectin (Siglecs), on the host cell surface, as the
coreceptor for T. cruzi mucin (Erdmann et al., 2009; Jacobs
et al., 2010). The Siglecs are a family of sialic-acid-binding
immunoglobulin-like lectins that promote cell–cell interactions
and regulate the functions of cells in the innate and adaptive
immune systems through glycan recognition (Varki and Gagneux,
2012). It was demonstrated that T. cruzi mucin engagement with
the Sia-binding protein Siglec-E promotes immunosuppression of
dendritic cells (DC; Erdmann et al., 2009).
TcTS ACTIVITY AND ITS ROLE IN HOST PARASITE
INTERACTION
TcTS is part of a protein family known as trans-sialidase/trans-
sialidase-like, encoded by more than 1,400 genes (El-Sayed et al.,
2005; Freitas et al., 2011). Members of the TcTS gene family can
be classiﬁed in ﬁve groups based on sequence similarity and func-
tional properties (Freitas et al., 2011). Active TS, also namely SAPA
(shed acute-phase antigen) expressed by the infective trypomastig-
ote (tTS) and the epimastigote TS (eTS) are grouped into Group
I. eTS and tTS have identical enzymatic activities, being highly
conserved in their primary sequences (Chaves et al., 1993; Briones
et al., 1995; Jager et al., 2008), except for the SAPA domain and
their 3′ UTRs, which are completely different in sequence (Jager
et al., 2007). Besides, eTS is a trans-membrane protein, while the
tTS is associated with the membrane via a GPI linker (Agusti et al.,
1997). Group II comprises members of the gp85 surface glyco-
proteins TSA-1, SA85, gp90, gp82, and ASP-2, which have been
implicated in host cell attachment and invasion. FL-160, a rep-
resentative of group III, is a complementary regulatory protein
that inhibits the alternative and classical complement pathways.
TsTc13, whose function is unknown, is the representative of group
IV and is included in the TcS superfamily because it contains the
conservedVTVxNVxL (Alves and Colli, 2008; Yoshida and Cortez,
2008; Souza et al., 2010). Recently a sequence clustering analysis
demonstrated that TS family is even more complex and may arbor
more groups and subgroups (Freitas et al., 2011).
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Several studies suggest that the TcTS can sialylate or desialylate
host cells modulating parasite adherence and penetration. Results
with Sia-deﬁcient mutants of Chinese hamster ovary (CHO) cells
support this hypothesis (Ciavaglia et al., 1993; Ming et al., 1993).
Sia deﬁcient cells were less infected than wild-type cells, suggesting
that sialylation of glycoconjugates on CHO cells surface is neces-
sary during T. cruzi invasion. Moreover, treatment of cells with
modiﬁed Sia precursors,N-propionylmannosamine and other N-
acylmannosamines, decreased cell invasion byT. cruzi (Lieke et al.,
2011). Importance of TcTS enzymatic activity in host cell inva-
sionwas elegantly proven using an irreversible inhibitor (Carvalho
et al., 2010a).
On the other hand, desialylation of sialoglycoproteins found
in the membrane of phagolysosomes by TcTS is thought to be
important for the escape of the parasite from the cytoplasm of
infected cells (Hall et al., 1992; Hall and Joiner, 1993; Rubin-de-
Celis et al., 2006).
Glycosylphosphatidylinositol-linked trypomastigote-derived
TcTS can be released into the extracellular medium in fairly high
amounts during acute T. cruzi infection in humans, thus acting
distant from the parasite as a soluble factor. Besides its role in
mammalian cell invasion, the soluble form of TcTS functions as
a virulence determinant molecule, and therefore, could have rel-
evant biological effects on the host immune system. It has been
demonstrated (Chuenkova and Pereira, 1995) that in vivo injec-
tion of tiny amounts of puriﬁed native TcTS increases subsequent
parasitemia and mortality in T. cruzi-infected mice. The effect
observed was speciﬁc for the transfer activity of TcTS because
it did not occur in mice primed with viral or bacterial sialidases.
The mechanisms responsible for these effects were not determined
but, since TcTS injection into deﬁcient SCID mice did not affect
parasitemia or mortality, it was suggested that the enzyme acts
on host lymphocytes of the acquired immune system (Chuenkova
and Pereira, 1995).
Indeed, multiple effects of TcTS on host T-lymphocyte func-
tion were additionally demonstrated. TcTS engagement with
α2-3-linked Sia-containing epitopes on CD43 (Todeschini et al.,
2002a) from CD4+ T cells triggers costimulatory responses that
increase mitogenesis and cytokine secretion, as well as promote
rescue from apoptosis (Todeschini et al., 2002b). These results
strongly suggest that TcTS could be a key parasite molecule induc-
ing host polyclonal lymphocyte activation, seen as a condition
underlying induction of immunopathology and hampering effec-
tive vaccination (Minoprio et al., 1989) in the course of T. cruzi
infection.
Given that surface sialylation might be crucial to decide the
ﬁnal fate of the cells during interaction with thymic lectins (Gille-
spie et al., 1993; Priatel et al., 2000) alteration of cell sialylation
by the soluble TcTS might inﬂuence thymocyte development. In
fact, alteration of the surface sialylation by TcTS (Mucci et al.,
2006) leads to in vivo depletion of the CD4+CD8+ double-
positive thymocytes inside the “nurse cell complex” (Leguizamón
et al., 1999). Interestingly, thymocyte apoptosis observed after
the sialyl residue mobilization requires the presence of andro-
gens (Mucci et al., 2005), suggesting the presence of a dimorphic
glycosylation survey in the development of the T cell compart-
ment that can be related to the observed differences in the
immune response among sexes (Gui et al., 2012). However, fur-
ther studies about the molecular mechanism involved in the
pro-apoptotic effect of TcTS are necessary. However, we can
speculate that TcTS activity can mask or expose β-Galp which
is recognized by molecules of the galectin family. Corroborat-
ing this hypothesis a role was reported for galectin-3 in death
of CD4+CD8+ immature thymocytes and migration of these
cells away from the thymus after T. cruzi infection (Silva-Monteiro
et al., 2007).
The impact of sialylation mediated by TcTS on CD8+ T cell
response of mice infected with T. cruzi is an exciting example of
how a parasite can manipulate host cell sialylation to favor par-
asitism. Following infection CD8+ T cell responses are robust
and persistent. However, they are signiﬁcantly delayed (Garg et al.,
1997; Tzelepis et al., 2007). This delay contrasts with the rapid
appearance of CD8+ T cell responses in other viral, bacterial
and even protozoal infections (Kaech et al., 2002), and suggests
a operative mechanism of immune evasion. During T cell acti-
vation, down-regulation of sialyltransferases (Amado et al., 2004)
renders potential Sia acceptors accessible to sialylation through
TcTS activity (Figure 4). This sialylation may be advantageous to
the parasite, since CD8+ T cells resialylated by TcTS present com-
promised Ag-speciﬁc responses and TcTS-treated mice present
increased parasitemia (Freire-de-Lima et al., 2010). Cell surface
Sia on CD8+ T cells might increase intercellular repulsion and
therefore weaken TCR/MHC class I-mediated cell–cell interac-
tions. This would be the opposite of the effect of neuraminidase
treatment, which removes Sia residues from various membrane
glycoproteins and enhances lymphocyte proliferation (Harring-
ton et al., 2000). In an attempt to establish the nature of the Sia
acceptor for TcTS on the CD8+ T cell surface, CD8+ T cells from
mice lacking the ST3Gal-I sialyltransferase, an enzyme required
for sialylation of core 1 O-glycans (Priatel et al., 2000), were
infected with T. cruzi. Loss of ST3Gal-I sialyltransferase exposes
the Galβ1-3GalNAc-Ser/Thr moiety creating an interesting model
to establish CD43 as a natural receptor for native TcTS during T.
cruzi infection. Indeed, infection of mice lacking ST3-Gal-I sialyl-
transferase restores, at least in part, binding of anti-CD43 S7 mAb,
which recognizes Sia-containing epitopes on CD43 of CD8+ T
cells. These ﬁndings indicated that CD43 is a target receptor for
TS on the CD8+ T cell surface. However, resialylation by TcTS was
also observed on CD8+ T cells from CD43 KO mice, suggesting
that in the absence of CD43 other molecules are substrates for
TcTS. Other studies using azido-modiﬁed unnatural Sia revealed
that CD45 isoforms are Sia acceptors for TcTS activity as well
(Muiá et al., 2010).
In infected individuals, alteration of cell surface sialylation
by TcTS can also compromise host cell homeostasis. Tribulatti
et al. (2005) demonstrated that the administration of TcTS into
uninfected mice was able to reduce the Sia content of platelets,
exposing terminal galactose residues, which may explain the
severe thrombocytopenia observed in T. cruzi infected individ-
uals. The recognition of terminal galactose moiety exposed on
the platelet surface accelerates platelet clearance by asialoglyco-
protein receptor-expressing scavenger cells (Sørensen et al., 2009).
The effect of TcTS on the lifetime of other cell types and plasma
glycoproteins must be further veriﬁed.
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FIGURE 4 | Representative scheme of the glycosylation status of CD8+
T cells duringT. cruzi infection. Naïve CD8+ T cells are heavily sialylated (A).
DuringT cell activation, down-regulation of sialyltransferases (ST) renders
potential sialic acid acceptors accessible to sialylation throughTcTS activity
(B). This sialylation may be advantageous to the parasite, because CD8+ T
cells resialylated byTcTS present compromised Ag-speciﬁc responses since
sialic acid charge might increases intercellular repulsion and therefore
weakensTCR/MHC class I-mediated cell–cell interactions (C). Absence of TS
may favor theTCR/MHC class I cell–cell interaction consequently,
development of the immune response (D).
Beyond host immune response, it has been observed that TcTS
alters the sialylation status of the tyrosine kinase receptor-A (TrkA)
in PC12 cells, which leads to receptor internalization, activation,
and neuronal differentiation (Woronowicz et al., 2004). Authors
demonstrated that the effects observed are triggered by hydrolysis
of Sia residues of TrkA by TcTS, as a puriﬁed recombinant α2–
3-neuraminidase but not a catalytically inactive mutant of TcTS
induced the receptor phosphorylation. Such enzymatic activity
might be involved in the neural repair and neuroprotection medi-
ated by the TcTS, also called T. cruzi-derived neurotrophic factor
(Chuenkova and Pereiraperrin, 2011).
The examples described in this section strongly suggest that
T. cruzi exploits the glycosylation of molecules expressed by the
host to evasion of the immune response, thus perpetuating the
infection.
INACTIVE TcTS
Inactive TcTS (TcTSY342H) is a parasite adhesin that differs from
the activeTcTSdue to a singlemutationof catalytic residueTyr342,
which is mainly changed by a histidine (Cremona et al., 1995). In
some T. cruzi strains, genes encoding TcTSY342H members are
present in the same copy number as those encoding TcTS (Cre-
mona et al., 1999). However, further studies should be performed
in order to address the expression levels and the ratio of the TcTS:
TcTSY342H protein on T. cruzi surface.
TcTSY342H is a unique adhesin containing two sugar binding
sites: one for α2,3-Sia and other for β-Galp (Todeschini et al.,
2002a, 2004; Oppezzo et al., 2011). Interestingly, the carbohydrate
recognition domain for β-Galp residue is formed only after a
conformational switch triggered by prior sialoside binding (Tode-
schini et al., 2004). The bivalent nature of TcTSY342H might
promote glycan cross-linking, which is believed to be essential
for cellular signal transduction.
The ﬁnding that inactive TS has two carbohydrate binding
domains, may explain some apparently contradictory results on
the involvement of sialyl and galactosyl epitopes in T. cruzi/host
cell interaction. While Schenkman et al. (1991) have shown that
sialylation of Ssp-3 epitope of mammalian cell-derived trypo-
mastigotes is required for target cell recognition, Yoshida et al.
(1997) reported that the removal of Sia from the surface of
insect-derived metacyclic trypomastigotes enhances parasite-host
interaction. The removal of Sia from T. cruzi glycoproteins and
the concomitant exposure of cryptic β-Galp residues would favor
TcTSY342H interaction with both host sialoglycoconjugates and
terminal β-Galp-containing glycoproteins on the parasite surface,
thus enhancingT. cruzi/host adhesion. This phenomenonwas well
characterized for CD22, a mammalian Sia-binding lectin (Varki
and Gagneux, 2012). The removal of Sia and concomitant expo-
sure of β-Galp residues from host cell glycans, which occurs as a
result of the T. cruzi TS reaction may, therefore, be physiologically
signiﬁcant by promoting parasite adherence to, and penetration
of host cells.
On the other hand, the parasite might use the active TS to sialy-
late host cell glycomolecules and generate receptors for TcTSY342H
mediating trypanosome adherence to a target cells. Data showing
that sialic acid-deﬁcient cells are less infected than wild-type cells
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(Ciavaglia et al., 1993; Ming et al., 1993), suggest that recognition
of sialyl residues on CHO cells by TcTSY342H is necessary during
T. cruzi invasion.
The hypothesis that TcTSY342H promotes glycan cross-linking
can be corroborated by data showing that both forms, active and
TcTSY342H, bind to α2,3-Sia from CD43 on host CD4+ T cells,
triggering a co-stimulatory response through mitogen-activated
protein kinase ERK1/2 cascade inducing mitogenesis (Todeschini
et al., 2002b). It was also shown that both forms of TcTS pro-
tect neuronal and glial cells from apoptosis through activation of
PI3K/Akt pathway and up-regulate the anti-apoptotic bcl-2 gene
(Chuenkova and Pereira, 2000; Chuenkova et al., 2001). Further-
more, we showed that TcTSY342H binds to α2,3-Sia containing
molecules on endothelial cells resulting in NF-κB activation,
expression of cell adhesion molecules and rescue from apoptosis.
Activation of endothelial cells increases trypomastigotes attach-
ment and invasion, suggesting that TcTSY342H plays a role in host
cell invasion during T. cruzi infection (Dias et al., 2008). Further
studies are required to establish the overall role of TcTSY342H in
the pathogenesis of Chagas’ disease. Data showing that TcTSY342H
competes in vivo with the native TcTS for Sia and β-Gal bind-
ing sites, inhibiting potential sialylation events from taking place
(Freire-de-Lima et al., 2010), might suggest that TcTSY342H bene-
ﬁts the host during T. cruzi infection. Decreased mortality of mice
treated with TcTSY342H suggests a role in prolonging parasite per-
sistence in host tissues and corroborates the role of TcTS-mediated
sialylation in the virulence of T. cruzi.
Yet the ability of T. cruzi to exploit host glycocalyx to attach
and establish the infection must be further studied as other inac-
tive members of TcTS might have lectinic properties. Two motifs
common to other sialidases, FRIP (xRxP) and Asp box, can be
found in various groups of the trans-sialidase-like family (Freitas
et al., 2011). The FRIP motif, involved in binding the carboxy-
late group of sialic acid (Gaskell et al., 1995), is found in four
out of seven groups of the trans-sialidase-like proteins. The Asp
box follows the FRIP motif and can be repeated up to ﬁve times
in the sequences of viral, bacterial, trypanosomatid, and mam-
malian sialidases. Although its function is unknown, it is worth
noting that the Asp box occurs in secreted proteins and in proteins
that act on, or interact with, carbohydrates (Copley et al., 2001).
Growing evidence has shown that the insect vector-derived meta-
cyclic trypomastigote uses its stage-speciﬁc surface molecule gp82,
which is member of the gp85/TS superfamily, to bind to gastric
mucin and establish T. cruzi infection in mice by the oral route
(Neira et al., 2003; Staquicini et al., 2010; Cortez et al., 2012).
Findings showing that TcTSY342H act as a lectin open a new
avenue to be explored in the interaction of T. cruzi and its hosts.
These studies raise thehypothesis thatTcTSY342H helps theparasite
to bind to surfaces rich in sialylated glycoconjugates. In addition,
TcTSY342H can act as a lectin triggering cellular signaling, or help-
ing the TcTS from T. cruzi surface to transfer and decorate the
cellular surfaces with Sia.
TcTS MECHANISM
TcTS is a retaining glycoside hydrolase (Todeschini et al., 2000)
member of the family number 33 (GH-33) that comprises the bac-
terial and eukaryotic exo-alpha sialidases (Withers and Williams,
2012). Unlike it’s closely related sialidase, TcTS preferentially
transfers sialic acid units to terminal β-Galp-containing molecules
and synthesizes α2-3-linkages exclusively. Efforts to decipher the
mechanismof TcTS catalysis have been important to the dissection
of the mechanism of exo-alpha sialidases (Watts et al., 2006; New-
stead et al., 2008) as these enzymes, unlike most of the retaining
glycoside hydrolases, do not present a carboxylate correctly placed
in the active site to act as a nucleophile. Pioneering studies with
ﬂuor-based sugar inactivators (Watts et al., 2003) followed by Lc-
MS/MS peptide mapping and then crystallography (Amaya et al.,
2004) demonstrated thatTcTSoperates through adouble displace-
ment mechanism involving the transient formation of a covalent
sialyl-enzyme intermediate with a Tyrosine (Tyr342), a very con-
served residue in exo-sialidases (Vocadlo andDavies,20083;Davies
et al., 2012), while D59 was proposed to act as a general acid/base
catalyst.
From such results a classical ping-pong mechanism (Damager
et al., 2008) was inferred for TcTS,where the sialosyl aglycone may
abandon the active site to allow the entry of acceptor substrate. In
this mechanism, as the sialic acid unit approaches the enzyme, it
displaces the Tyr119 away from the binding site (Buschiazzo et al.,
2002), its carboxylate group interacts with the Arg triad (Arg35,
Arg245, Arg314), while its acetamido group interacts with Asp96.
Such interactions induce planarization of the sialic acid moiety
around the oxygen ring, with C1, C2, and C3 assuming a 4H5
conformation during the transition state. The C2 suffers nucle-
ophilic attack by Tyr342, assisted by Glu230 acting as a general
base, and a covalent linkage is formed. The covalent intermediate
assumes a 2C5 conformation. The aglycone leaves the catalytic
cleft, thus making space for binding of the sialic acid accep-
tor. Transfer to the acceptor would then occur through attack
of the C2 of the sialyl-enzyme intermediate by the 3-OH group
of a lactose moiety, or by water (as in other sialidases) which
must be deprotonated by the residue acting as acid/base cata-
lyst, Asp59 (Damager et al., 2008). Nevertheless, a mechanism
that supports the higher rates for the transfer reaction requires
signiﬁcant conformational changes in the catalytic pocket during
substrate binding and catalytic turnover, features not captured in
TcTS crystals yet.
Numerous studies that show evidence for the plasticity of the
TcTS catalytic cleft have been arisen. For instance, from molec-
ular dynamics simulations it is known that the key hydropho-
bic residues Y119 and W312 confer ﬂexibility to the catalytic
cleft mouth and allow substrates to access the catalytic pocket
in a controlled manner (Demir and Roitberg, 2009; Mitchell et al.,
2010). Other key residues, which possibly contribute to the plas-
ticity of binding site, were identiﬁed by mutagenesis studies (Paris
et al., 2001; Carvalho et al., 2010b) or by hybrid quantum mechan-
ics/molecular mechanics simulations (Pierdominici-Sottile and
Roitberg, 2011). Crucial evidence for such plasticity rose from the
observation that the TSY342H (Todeschini et al., 2002a) undergoes
large conformational changes, upon sialoside binding, leading the
overture of a second binding site that accommodates a β-Galp
moiety (Todeschini et al., 2004). Active site rearrangement follow-
ing the sialoside engagement was further proposed for the fully
active TcTS (Haselhorst et al., 2004). Nuclear magnetic resonance
spectroscopy conﬁrmed that association of the β-Galp within the
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TcTS active site succeeding the sialic acid donor is necessary for
the transfer reaction to proceed (Haselhorst et al., 2004). Results
of TSY342H incubated with α2-6-sialyllactose in the presence of
lacto-N-tetraose, showing that incorrect ﬁtting of sialoside into
the binding site of TS does not trigger β-Galp binding, corrob-
orate this hypothesis. Furthermore, surface plasmon resonance
results showing that lactose binds to an inactive mutant of TSD59N
in the presence of α2-3-sialyllactose (Buschiazzo et al., 2002).
This discussion shows that further structural data are needed
to shed light into the reaction mechanism that underlies efﬁcient
sugar transfer activity rather than simple hydrolysis byTcTS.Given
that genomic analysis suggests that TcTS proteins have several
point mutations (Freitas et al., 2011), structural and mechanis-
tic works must be persistent, as mutations in key amino acids
(Paris et al., 2001; Carvalho et al., 2010a) would produce critical
modiﬁcations in TcTS catalysis and speciﬁcity.
INHIBITION OF SIALIC ACID TRANSFERENCE BY TcTS
Together, the above observations support the hypothesis that TcTS
enhances T. cruzi virulence by altering host immune responses
directed against the parasite. The facts that TcTS presents low
homology with mammalian sialidases, and that it is the lonely
protagonist for sialic acid acquisition by T. cruzi, provide a ratio-
nale for a new potential intervention strategy in chemotherapy of
Chagas’ disease. Beyond the urgency of alternative drugs to treat
the illness, to pursuit of TcTS inhibitors has been the target of
several research groups that aim to clarify the role of TcTS in the
pathogenesis of Chagas’ disease. However, compounds that effec-
tively inhibit the catalytic activity of TS have not been described.
The advances made in this ﬁeld were somehow indirect, relying on
few strategies like the use of neutralizing antibodies, given that the
siRNAmechanismof gene silencing inT. cruzi is lacking, andTcTS
is coded by multiple genes copies (Freitas et al., 2011) making gene
deletion experiments unlikely to be successful (Balaña-Fouce and
Reguera, 2007).
Although effective TcTS inhibitors have not yet been reached,
efforts made in this area have found interesting lead compounds.
The molecules so far tested as TcTS inhibitors are described below
as compounds that are analogs to donor or acceptor substrates and
compounds that are unrelated to TcTS substrates (Figure 5).
DONOR SUBSTRATE ANALOGS (Figure 5)
Unlike the inﬂuenza neuraminidase, TcTS activity is barely inhib-
ited by 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA),
a transition state analog (Paris et al., 2005), or by its analo-
gous 5,6-dihydro-4H-pyran-2-carboxylic acid derivatives includ-
ing zanamivir (Neres et al., 2006).
Despite the observed success with the use of S-glycosides as
inhibitors of glycosidases including sialidases (Watson et al., 2006)
theNeu5Acα2-3-S-Galβ-O-octyl was found to show no signiﬁcant
inhibition of TcTS even at millimolar concentrations (Harrison
et al., 2001). The low inhibition rates observed by the Neu5Acα2-
3-S-Galβ-O-octyl suggest that the conformations acquired by this
compound in solution might not be recognized by the TcTS.
This theory can be supported by NMR studies of the confor-
mational distribution of cellobiose and S-cellobiose linked to
the Streptomyces sp. β-glucosidase. These data showed that the
S-cellobiose presents three conformational families, unlike cel-
lobiose which is only found in two conformations in solution
(Montero et al., 1998).
Trapping of the 2,3-diﬂuorosialic acid by the Tyr342 hydroxyl
group opened new avenues for the design of irreversible inhibitors
for TcTS (Watts et al., 2003). 2,3-Diﬂuorosialic acid temporar-
ily inactivates the TcTS through covalent binding with the
hydroxyl group of Tyr342. However, complete inactivation
requires very high concentrations of inhibitor (20 mM) and
the enzyme spontaneously recovers its full catalytic activity
(Watts et al., 2003). Incorporation of aryl groups at C9, like
umbelliferyl, benzamide, and 4-(phenyl carbamide) butyra-
mide, led to more than 1000-fold decrease in TcTS reactivation
(Buchini et al., 2008). The crystal of the 9-benzoyl-3-ﬂuoro-N-
acetylneuraminic acid within TcTS showed that the presence
of a voluminous group induced a reorientation of the glycerol
side chain, which instead interacts with Tyr119, a site occu-
pied by acceptor substrate, explaining low enzyme reactivation by
lactose.
An elegant approach for the irreversible inhibition of TcTS was
achieved with the 2-diﬂuoromethyl-4-nitrophenyl-3,5-dideoxy-
D-glycero-α-D-galacto-2-nonulopyranosid acid (Neu5AcFNP)
and 5-acetamido-2-(4-N-5-dimethylaminonaphthalene-1-sulfo-
nyl-2-diﬂuoromethylphenyl)-3,5-dideoxy-D-glycero-α-D-galacto-
2-nonulopyranosonic acid (dansyl-Neu5AcFP). Characterization
of trapped enzyme by mass spectrometry analysis revealed that
inactivation of enzyme occurs through a covalent bond forma-
tion between the Arg245 and Asp247 residues with the reactive
aglycone generated by the hydrolysis of dansyl-Neu5AcFP. Note-
worthy is that Neu5AcFNP inhibited infection of mammalian cells
by T. cruzi trypomastigotes (Carvalho et al., 2010a).
Apart from complex sugar frameworks, some cyclic scaffolds
simulating hexose-like moieties, such cyclohexene, benzoic acid,
and pyridine-based structures, were tested. A quite simple pyri-
doxal phosphate structurewas reported as aweak non-competitive
TcTS inhibitor (Ferrero-García et al., 1993). The same feature was
observed for two N-acetyl-clyclohexene phosphonate monoalkyl
esters (Streicher and Busse, 2006). Trials using a series of piridine-
2-carboxylic acid and benzoic acid derivatives described the 4-
acetylamino-3-hydroxymethylbenzoic acid as the best compound,
with a Ki value of ∼300 μM (Neres et al., 2007). Curiously, this
benzoic acid derivative had the same layout as the best cyclohex-
ene phosphonate derivative from the work of Streicher and Busse
(2006), evidencing a negative charged group, N-acetyl at opposed
carbons and a hydroxyl group as pharmacophoric moieties for
TcTS inhibition.
ACCEPTOR SUBSTRATE ANALOGS (Figure 5)
In face of fruitless efforts to inhibit TcTS by occupying the donor
substrate site, some groups have targeted the acceptor binding site.
Lactitol was able to competitively inhibit the TcTS reaction and
to interfere with parasite infection in cultured cells (Agusti et al.,
2004). Latermodiﬁcations of the lactitolmolecule, by addingGalp,
Galf, or benzyl, led to a pentasaccharide with an IC50 of 0.61 mM
(Agusti et al., 2007).
The acceptor substrate for theTcTS transfer reaction (Galp)was
also used as a source of inspiration for click chemistry synthesis of
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FIGURE 5 | Compounds tested asTcTS inhibitors.
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triazoles-substituted saccharides. Starting from galactose deriva-
tives bearing an azide group at C1 or C6, a triazol-
substituted saccharide library was made and tested against TcTS.
Despite its low inhibitory activity against TcTS, the N-methyl
benzylamide derivative presented trypanocidal activity (Carvalho
et al., 2010b).
Recently, a series of octyl galactosides and octyl N-
acetyllactosamines were tested against TcTS. Results showed that
the TcTS acceptor binding site is intolerant of substitution of β-
Galp at positions 2 and 4, whereas substitution at position 6 of
the Gal ring is well accepted, highlighting the potential of 6-
substituted Gal residues as TcTS acceptor substrates (Harrison
et al., 2011).
UNRELATED SUBSTRATE COMPOUNDS (Figure 5)
The 3-benzothiazol-2-yl-4-phenyl-but-3-enoic acid and sulfon-
amide scaffolds emerged, from virtual screening, as new frame-
works for TcTS inhibition (Neres et al., 2009). Sulfonamides
ﬁgured also as good substituents for chalcones used as TcTS
inhibitors by Kim et al. (2009). Of the compounds tested, the
tetrahydroxylated quinolinone inhibits both hydrolytic and TcTS
activities at millimolar concentration (Kim et al., 2009). Similar
to chalcones, various ﬂavonoids and anthraquinones were sys-
tematically screened from a large library. A highly hydroxylated
anthraquinone was the best inhibitor of TcTS,with an IC50 of 0.58
μM(Arioka et al., 2010). Moreover, this compound did not inhibit
Neu2, amammalianneuraminidase, demonstrating that its inhibi-
tion is reasonably speciﬁc to TcTS (Arioka et al., 2010). Therefore,
this last structure represents, to date, the most promising scaffold
for a TcTS inhibitor.
Despite great advances made toward TcTS inhibition, works
highlighting the enzyme’s plasticity (Demir and Roitberg, 2009;
Mitchell et al., 2010) showing the existence of an acceptor
binding site (Todeschini et al., 2004; Damager et al., 2008) sug-
gest that the structure of TcTS with two cavities would be
a better framework for rational drug design aimed to TcTS
inhibition.
PERSPECTIVES
Sia participate in a large range of biological processes between T.
cruzi and its host, and just a few examples are considered here. In
fact, the effect of Sia in the pathogenesis of Chagas’disease remains
unknown.
Given the role of Sias as “self-associated molecular patterns”
recognizedbymolecules such as Siglecs (Paulson et al., 2012), TcTS
activities can perturb natural self-recognition phenomena, per-
haps increasing inﬂammatory responses by exposing desialylated
“danger-associated molecular patterns” (Varki, 2011; Rabinovich
et al., 2012).
Moreover, from evidence showing that desialylation of Toll-like
receptor 4 (Amith et al., 2010; Abdulkhalek et al., 2011) is essen-
tial for receptor activation and cellular signaling, we can speculate
that TcTS can also modify host response to “pathogen-associated
molecular patterns.”
Recent advances in the glycobiology ﬁeld will surely help to
understand how a glycosidase evolved to have a highly efﬁcient
trans-glycosidase activity and to put forward the design of speciﬁc
and potent TcTS inhibitors. These molecules will help to disclose
the real roles of TcTS/sialoglycoproteins in T. cruzi biology, the
pathogenesis of Chagas’ disease, and perhaps help the treatment
of this illness.
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